Skip to main content
Fig. 5 | Radiation Oncology

Fig. 5

From: Efficacy and safety of radiotherapy plus anti-PD1 versus transcatheter arterial chemoembolization plus sorafenib for advanced hepatocellular carcinoma: a real-world study

Fig. 5

Kaplan–Meier analysis of overall and progression free survival in patient subgroups. A OS among patients with BCLC-C; B OS among patients with MVI; RT Radiotherapy; PD1 Monoclonal antibody against programmed cell death; TACE Transcatheter arterial chemoembolization; OS Overall survival; PFS Progression-free survival; BCLC-C Barcelona Clinic Liver Cancer C stage; MVI Macrovascular invasion; AFP Alpha-fetoprotein

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us